読み込み中
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
前日終値
$8.89
+$0.42 · +4.96%
日中の時刻はETです。市場データは遅延する場合があります。
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
日中レンジ
現在 $8.89
52週レンジ
現在 $8.89
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
売り
バリュエーション
53
適正価値
センチメント
50
まちまち
リスク
77
高リスク
モメンタム
42
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
日中レンジ
現在 $8.89
52週レンジ
現在 $8.89
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 7736.3万 USD | 7986.6万 USD | 8105.6万 USD | 7133.1万 USD | 4895.6万 USD |
| 売上原価 | 1069.7万 USD | 1158.1万 USD | 1188.1万 USD | 1236.1万 USD | 861万 USD |
| 粗利益 | 6666.6万 USD | 6828.5万 USD | 6917.5万 USD | 5897万 USD | 4034.6万 USD |
| 研究開発 | 1460.6万 USD | 1799.1万 USD | 1755.6万 USD | 2285.9万 USD | 1563.4万 USD |
| 販売・一般管理 | 8915.9万 USD | 1.01億 USD | 1.09億 USD | 1.2億 USD | 7619万 USD |
| 営業費用 | 1.04億 USD | 1.19億 USD | 1.26億 USD | 1.43億 USD | 9182.4万 USD |
| 受取利息 | 397.3万 USD | — | — | — | — |
| 支払利息 | 514.2万 USD | 466.2万 USD | 540.8万 USD | 446.6万 USD | 436.6万 USD |
| 減価償却費と償却費 | 48.7万 USD | 71.2万 USD | 61.4万 USD | 71万 USD | 63.2万 USD |
| 営業利益 | −3709.9万 USD | −5053.2万 USD | −5727.4万 USD | −8395.4万 USD | −5147.8万 USD |
| 純利益 | −3842.6万 USD | −5150.7万 USD | −5554.7万 USD | −8624.2万 USD | −6296万 USD |
会社概要が更新されました 2026年10月11日.
発表済み実績と利用可能なコンセンサス予想。
発表済み実績と利用可能なコンセンサス予想。
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$7.00
下落余地（21.26%）この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI971.04万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM891.23万0.01%787.4億 USD0.19%$278.94+0.49%
Vanguard Extended Market ETFVXF347.03万0.00%954億 USD0.05%$235+0.80%
iShares Russell 2000 Growth ETFIWO301.43万0.02%139.17億 USD0.24%$356.78+0.94%
Vanguard Russell 2000 ETFVTWO191.81万0.01%180億 USD0.06%$112.66+0.50%
Schwab U.S. Small-Cap ETFSCHA176.08万0.01%218.24億 USD0.03%$32.79+0.40%
Invesco Dorsey Wright SmallCap Momentum ETFDWAS170.59万0.43%3.99億 USD0.60%$107.24+1.40%
Dimensional - US Small Cap ETFDFAS122.71万0.00%338.69億 USD0.31%$78.35+0.32%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAInvesco Dorsey Wright SmallCap Momentum ETFDWASDimensional - US Small Cap ETFDFASAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
